Brookfield Renewable Corporation <BEPC.N>: Barclays raises target price to $39 from $36
BEPC•Related News
BridgeBio says FDA accepts encaleret NDA for ADH1, sets May 8, 2027 PDUFA date
BBIO•
Johnson & Johnson's robotic surgery device gets US marketing authorization
JNJ•
Shipping firm High-Trend International's H1 revenue rises on dry bulk demand
HTCO•
CME Group beats profit estimates as hedging demand lifts equity volumes
CME•
Dr. Reddy’s Q1FY27 profit after tax drops 69% YoY to ₹4.44 billion; revenue falls 5.6% YoY to ₹80.71 billion
RDY•